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On The Threshold of a New Era 
H isrory will remember 1990 as a year of nearly revo-lutionary change, a year when the political realities of the Cold War era disintegrated almost overnight and were replaced with a new political and eco-nomtc order. The year 1990 is the threshold for 
entry into a new era of great opportunities and prospects. On a 
personal, institutional, and international level, it is a good time to 
initiate new ventures and to explore new directions and new ap-
proaches ro old problems. 
The year 1990 is also an important threshold for The ]oumal of 
fm,esrigarive Dermarolo~y. The five-year contract recently signed 
with Elsevier Science Publishing Company provides unprecedented 
benefits for the journal and its sponsoring societies, the Society for 
Investigative Dermatology and the European Society for Dennato-
logical Research. Beginning in 1991, we will for the first time have 
sufficient guaranteed editorial pages to publish all of the papers 
submined that meet the standards of the JID. Because of the 
strength of the journal and the new arrangement wirh Elsevier, and 
with the support of funds from the Endowment established during 
the Fiftieth Anniversary Year of the journal, we will be able to 
provide special supplemental issues and other features in addition to 
primary research papers. 
With the prospect of a larger and more diverse journal, rhe imme-
diate goal of the Editorial Board is to make the JID more accessible 
to all aspects of research in cutaneous biology. Techniques in molec-
ular and cellular biology are being applied with great impact co 
questions in cutaneous biology and ro the study of skin diseases. We 
want to assure that such papers submitted to the /ID receive rapid 
review by acknowledged experts so that the whole spectrum of 
research related to the skin and skin disease is represented in this 
journal. The Edirorial Board is being expanded to include new 
Associate Edirors expert in the disciplines of keratinocyte biology, 
immunology. extracellular matrix, genetics, pharmacology, bio-
physical properties, and virology. We will especially strive for 
greater participation of the Ph. D. basic scientist in our new Editorial 
Board configuration, reflecting the expanded participation of such 
investigators in cutaneous biology. At the same rime, we are inter-
ested in maintainittg our accessibility for research applied directly 
to dermatologic diseases, and have added a dermaropathologist to 
consider the research submitted by rhis very active group of investi-
gators. 
A crucial factor in the attraction of high-impact research ro the 
JID is the ability to provide rapid review and publication of articles 
on the cutting edge of modern investigation. W e will provide a 
special "fast crack" for rapid review and publication for ten percent 
of our submissions. These papers will receive expedited handling in 
the Editorial Office and at the publisher. Our goal for such selected 
High Impact manuscripts is four months from when a submitted 
paper is received in our office until it appears in an issue of the 
journal, excluding any time necessary for revision. As indicated in 
the new Information for Authors, we invite authors to request that 
appropriate submissions be designated High Impact papers, but the 
assignment of this fast ttack category will be decided by rhe Edito-
rial Board. 
We will also institute changes in the review process to diminish 
the time in review of regular JID submissions. Please refer to the 
new author instructions for details related to submission of papers. 
Authors will be asked to submit four copies of manuscripts 
plus illustrations for all types of submission. New approaches 
will be employed in rhe Editorial Office to eliminate late reviews. 
Although the use of modern telecommunications will help to di-
minish time in review, the most important delay in our process is 
due to overdue review or reviewers who return manuscripts unre-
viewed after extended delays. I implore the reviewers for this jour-
nal to perform their requested reviews in a timely manner with 
appropriate consideration for the authors. 
The Rafid Communication will remain a mechanism for pub-
lication o short, succinct contributions that demonstrate novel 
techniques or findings, also published in an expedited manner. 
Another important way to attract attention to research in cutane-
ous biology and ro showcase such work in the JID is the Review 
Article. As noted in the Information for Authors, we will accept 
submission of review articles from the membership for peer review. 
We will also solicit such articles from scientists across the whole 
spectrum of biology, including those nor closely associated with 
cut:meous biology. Instructions on submission of Review Articles 
can be found in the new Information for Authors. 
The Editorial Board will continue to organize special supplemen-
tal issues and mini-supplements within regular issues ro focus atten-
tion on rapidly progressing areas of research, to identify and describe 
new techniques being applied to research in cutaneous biology, and 
to report on symposia demonstrating the application of basic labora-
tory techniques to the study of the mechanisms and treatment of 
skin diseases. 
Authors submitting papers to the JID are now able to select H igh 
Impact, Rapid Communication, or Review Article in addition to a 
regular submission. Such submissions will be considered by an Edi-
torial Board with broader expertise in clinical and basic research. 
The Editorial Process will be streamlined and, with the help of 
reviewers and authors, time in review will be decreased. For High 
Impact papers, rapid publication is guaranteed. 
There is great promise in the new era which the JID now enters. 
We seck broader representation ofbasic and clinical scientists in all 
disciplines of cutaneous biology, and will continue to use a broadly 
based international reviewer base to provide thorough and timely 
peer review. 
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